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Abstract
Introduction
Researchers are increasingly using routinely collected data in addition to, or instead of, other data
collection methods. The UK government continues to invest in research centres to encourage use of
these data, and trials and cohort studies utilise data linkage methods in the follow-up of participants.
This does not come without its limitations and challenges, such as data access delays.
Objective
This paper outlines the challenges faced by three projects utilising individual-level routinely-collected
linked data for the longer-term follow-up of participants.
Methods
These studies are varied in design, study population and data providers. One researcher was common
to the three studies and collated relevant study correspondence, formal documentary evidence such as
data sharing agreements and, where relevant, meeting records to review. Key themes were identified
and reviewed by other members of the research teams. Mitigating strategies were identified and
discussed with a data provider representative and a broader group of researchers to finalise the
recommendations presented.
Results
The challenges discussed are grouped into five themes: Data application process; Project time-
lines; Dependencies and considerations related to consent; Information Governance; Contractual. In
presenting our results descriptively we summarise each case study, identify the main cross-cutting
themes and consider the potential for mitigation of challenges.
Conclusions
We make recommendations that identify responsibilities for both researchers and data providers
for mitigating and managing data access challenges. A continued conversation within the research
community and with data providers is needed to continue to enable researchers to access and
utilise the wealth of routinely-collected data available. The suggestions made in this paper will help
researchers be better prepared to deal with the challenges of applying for data from multiple data
providers.
Focus of this article
• Routinely-collected data are increasingly accessed in
health and social care research however there are
challenges for researchers working with multiple data
providers
• This paper outlines the challenges faced by three stud-
ies accessing data from a number of data providers in
England and Wales
• Recommendations, based on the experience of these
studies, are made for researchers to consider and incor-
porate into future studies accessing routinely collected
data
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Introduction
The use of routinely-collected data in health research is in-
creasing and expanding to enable more efficient trial designs at
a reduced cost (1–4). Using data available on populations on
a national, European and global scale creates an opportunity
to benefit health research in academia and beyond (5). Over
recent years, the UK government and devolved administrations
have invested in a number of e-health and administrative data
networks to encourage innovations in this area, including the
£100m investment of the Medical Research Council (MRC)
since 2012 into awards for initiatives such as the Farr Institute.
Similarly, the MRC and other UK funders recently announced
their commitment of £37.5m over five years to “transform the
UK medical informatics research landscape” through Health
Data Research UK (6).
In a trial setting, typical risks and potential biases
to a project include participant recruitment and retention.
Routinely-collected data can identify potential study subjects
and reduce data collection required from participant, thereby
addressing some of these. However, it may also add risk, for
example, in gaining appropriate access. Accessing routinely-
collected data has previously been described as “virtually im-
penetrable terrain, hostile to the research pioneer” (5). De-
lays in accessing data from providers can be due to the legal
landscape governing the use of data for research and the di-
verse frameworks implemented by data providers to support
decision-making for data applications (5,7). These challenges
are well documented (8) and despite calls for improvement
(9) researchers still struggle to access data for studies (10).
The legal and ethical aspects of accessing, using or linking
health data have received more critical attention than other
administrative data, such as social care (11–13). Beyond the
frustrations and time taken to access data, these challenges
have wider impacts on research. Lack of anticipated access to
follow-up data reduces sample size and increase risk of bias,
loss of confidence by funders in organisations to deliver re-
search, and wasted money spent on accessing data rather than
analysis, interpretation and knowledge dissemination.
Using our recent experience from three studies, across
different populations and data providers (Health, Education
and Social Care), we aim to summarise some key challenges,
lessons learned and solutions in accessing routinely collected
data for the longer-term follow-up of trial and cohort partici-
pants.
Methods
We used a narrative case study approach to identify themes
and suggest solutions to arising challenges. Three studies were
selected opportunistically as examples of current work under-
taken by the same research centre and involving use of data
from multiple data providers. We included studies that are
varied in design, study population and data providers (Table
1). For each we summarised in tabular form key features of the
study design, particularly aspects related to routinely-collected
data. One researcher was common to the three studies (RCJ)
and FLW led on collating relevant information. This included
discussions with each of the respective research teams (in-
cluding the Chief Investigators: MR, KHu), review of relevant
study correspondence (e.g. emails), formal documentary ev-
idence such as data sharing agreements and, where relevant,
meeting records. Each case study therefore represents the
individual study design, application process and subsequent
receipt of data.
The lead researcher identified key themes in a first stage
of analysis. While not necessarily problems, these were chal-
lenges presented to the study teams involved. Summaries of
challenges were reviewed by other members of the research
team. In this process, potential and/or employed mitigat-
ing strategies were identified. To ensure that the perspective
was not solely that of the research teams involved, the draft
summary was shared with a data provider representative (GC).
This provided an opportunity for validation from a key external
stakeholder and importantly a means to establish the feasibil-
ity of suggested mitigation strategies (for example where there
was interface with the data centre). Finally, a broader group
of researchers (all from the same research centre) with an in-
terest in research using routinely-collected data were invited
to comment on a draft summary document.
First, we describe the three contributing studies:
The Building Blocks Trial
The Building Blocks Trial (BB:0-2) was a Randomised Con-
trolled Trial (RCT) assessing the effectiveness of the Fam-
ily Nurse Partnership (FNP) home-visiting programme when
added to usual care, as compared with usual care alone, for
young mothers and their first child living in England. The trial
utilised prospective data collection along with use of routinely-
collected data from birth records, GP practices, abortion data,
death data from the Office for National Statistics (ONS) and
hospital data from NHS Digital (NHSD) (at the time, Health
and Social Care Information Centre) (14,15). Participants pro-
vided their explicit consent for data linkage.
The Building Blocks follow-on study
The Building Blocks: 2-6 Study (BB:2-6) involves the same
participants as the BB:0-2 trial, but with a primary focus
on maltreatment. The follow-up of this cohort is solely via
routinely-collected data and is without explicit consent (opt-
out model supported by Section 251 approval). Data include
abortion data (16), ONS data, hospital data from NHSD (17),
education data and social care data from the National Pupil
Database (NPD)(18).
The LUCI Study
The LUCI Study (The Long-term follow-up of Urinary Tract
Infection (UTI) in Childhood) is an electronic record-linked
study following up two cohorts of children living in England
and Wales who consulted a GP with acute illness when aged
5 or under during either the DUTY (19) or EURICA study
(20). Follow-up data will include hospital and GP data from
the Secure Anonymised Information Linkage (SAIL) Databank
(21–23), Microbiology culture data from Public Health Wales
(via SAIL) and hospital data from NHSD.
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Data Providers
The data providers discussed in this paper are as follows:
NHS Digital (NHSD) is the Data Controller for clinical data on
patients in England, for example from hospital records, cancer
registrations, patient demographics and also mortality data
available from the Office for National Statistics (ONS)(17).
The Department for Education is the Data Controller for
the NPD, which includes information sourced from English
publicly-funded schools, local authorities and awarding bod-
ies (24). SAIL Databank provides clinical data on patients in
Wales including from GP, hospital and the Welsh demographic
service. SAIL also act as a data safe haven, providing secure
storage and access to data via their remote portal. The De-
partment of Health is the Data Controller for the data held
within the Abortion Statistics Team (AST) provide data on
terminations of pregnancies to ‘bona fide researchers’ for ap-
proved requests (16). See Table 2 for a summary of the Data
Providers’ application and publishing requirements.
Other key committees / organisations
The Confidentiality Advisory Group (CAG) provides indepen-
dent expert advice to the Health Research Authority on the
use of confidential patient information (25). The UK is gov-
erned by the Information Commissioner’s Office, an indepen-
dent body set up to uphold information rights as per data
protection legislation (26).
In presenting our results descriptively we will summarise
each case study, the main cross-cutting themes identified and
the potential for mitigating challenges identified.
Results
The identified challenges are collated under five headings:
Data application process; Project timelines; Dependencies and
considerations related to consent; Information Governance;
and Contractual. Table 3 summarises the challenges and po-
tential mitigating actions.
1. Data application process
The key challenges identified under this theme are changes of
requirements over time, the length of the application process
and the differing requirements among UK data providers.
Study approval process
Until recently, NHSD would not accept an application until
the ethical approval letter, and other approvals such as le-
gal approval for linking data (section 251), were uploaded as
part of the application. For some projects, NHSD applica-
tion approval relied on Section 251 support, which in turn
relied on ethics approval; one application could not proceed
until the previous requirement was fulfilled. The same was
true for any substantial amendments required to the study.
NHSD are now working with Health Research Authority and
other organisations to identify areas for improvement which,
includes allowing approvals to be submitted in parallel rather
than sequentially (18).
Changes over time
We experienced a number of changes to application forms,
approval processes and review panels (members and remit)
during the lifecycle of the three studies. These changes in
governance reflect data providers’ ensuring data releases are
in the public benefit and comply with data protection law and
ethical standards. In the case of NHSD, changes were also a
response to the PriceWaterhouseCooopers Data Release Re-
view Audit overseen by Sir Nick Partridge (27,28) and to public
concerns about care.data (29). This in turn extended timelines
for the re-drafting and re-submission of a data request applica-
tion and delays from the data providers whilst staff and panel
adapted to the changes and communicated with the applicant
accordingly.
Length of application process
In our three studies, the duration of time between submission
and signing the data sharing agreement (at which point data
can be transferred between the two organisations) ranged from
two months to 18 months depending on the data provider and
when the data were requested (e.g. during a period of change
as above). Table 1 outlines the various data providers and
associated timelines.
For BB: 2-6, once the application was in the new tem-
plate NHSD progressed it to the review panel within a rea-
sonable timeframe (three months) in February 2015 and three
points were noted as the reason for not approving the appli-
cation. Once these were addressed, instead of re-review by
the panel, the internal review process then identified further
queries/comments over a period of 11 months (two periods of
change, six rounds of internal review, three different case offi-
cers assigned) preventing its recommendation to be considered
by the NHSD Panel until February 2016.
The queries and comments raised by the internal (pre-
panel) review were incorporated into the BB:2-6 application
and where relevant informed the application for the LUCI
study. A combination of these lessons learned (Box 1), no pe-
riod of change, and the continuity of one case officer through-
out the process enabled the LUCI study application to receive a
four-and-a-half-month turnaround from submission of a com-
pleted application to signed data sharing agreement (enabling
data transfer).
NHSD listened to criticisms raised by the researcher com-
munity and have responded with further guidance, webinars
and increased communication. Communication via audio con-
ferences between the research team and NHSD, in partic-
ular with the case officer presenting the application to the
panel and the data analyst preparing the data, also enabled
greater understanding of the application and a faster response
to queries raised.
Differing requirements
The information required, including the level of detail, the
application forms, and the review panel remit, differ across
data providers. This is partly down to the nature of the data
provider and the legal requirements placed on them regarding
release of data. NPD for example are not required to com-
ply with the Health and Social Care Act 2012 (30) whereas
NHSD are, placing a focus on the applicant to demonstrate
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Table 1: A summary of the three case studies – BB:0-2 Trial, BB:2-6 Study and LUCI Study.
BB:0-2 Trial BB:2-6 Study LUCI Study
Ethical Approval Ref. 09/MRE09/08 14/WA/0062 16/WA/0166
Legal basis for linking data1 Explicit consent s2513 Ref. CAG 10-
08(b)/2014 s42(4) of the
Statistics and Registration
Service Act 2007 6 (1) of
Schedule 2 of the 1998 Data
Protection Act
s251 Ref. 16/CAG/0114
Primary Outcome(s) Subsequent pregnancy;
Smoking in late pregnancy;
Emergency hospital at-
tendance and admissions;
Birthweight
Child in Need status Renal Scarring
Funder Department of Health Policy
Research Programme.
National Institute for Health
Research, Public Health Re-
search Programme (NIHR
PHR)
Health and Care Research
Wales
Population Young mothers and their first-born child(ren) Children <5 years presenting
with acute illness in Primary
Care
Study design RCT RCT with longer term follow-
up using routine data
Cohort with longer term
follow-up using routine data
Location of data for analysis Cardiff University server SAIL data safe haven SAIL data safe haven
Data providers & Timelines2
NHS Digital (including ONS) 5 months (2013-2014) 18 months (2014-2016) 4.5 months (2017)
Abortion Statistics team 1 month (2012) 2 months (2017) N/A
National Pupil Database N/A 7 months (2016) N/A
SAIL N/A N/A 5 months (2016)
1At the time of approval; 2The duration of time between submission and signing the data sharing agreement (at which point data
can be released); 3Section 251 of the Health and Social Care Act 2012.
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Table 2: Overview of the relevant Data Providers
NHS Digital ONS (via NHSD) NPD SAIL Abortion Statistics
Team
Approval of data
application
Independent Group Advising on
the Release of Data (IGARD
Panel)
Tier 1 data1: Data
Management
Advisory Panel
Tier 2-4 data2:
Education Data
Division
Information
Governance Review
Panel
Chief Medical
Officer
Evidencing IG3
requirements
Data Security and Protection
(DSP) Toolkit (Previously IG
Toolkit)
Information Secu-
rity Questionnaire
Remote Access
only
Study-specific
basis
Data access cost Available on Website No Cost Available on
Request
No Cost
Approval
timelines
3 Tier system (15; 30 & 60 days)
stop-clock
Not available Estimated 12
weeks
Not available
Contractual Organisation
Framework
agreement
Project level
Data Sharing
Agreement
(DSA)
As per NHSD + In-
dividual
Declarations
Project level DSA
Individual Declara-
tions
Person level User
Agreement
Project level DSA
Publication
requirements
Acknowledgement Acknowledgement
Disclosure
control for cell
counts <3
Acknowledgement
Notification prior
to publication
Acknowledgement
Notification on
acceptance of
publication
3 references
provided for
inclusion
Disclosure
control for cell
counts <5
Acknowledgement
Notification prior
to publication
Disclosure control
for cell counts <9
Maximumt
duration of
contract
3 years 1 year 3 years Project-specific
(and within the
funded period for
SAIL)
3 years
1Tier 1 data are the most sensitive personal information; 2Tier 2, 3 & 4 data are other sensitive personal information, school level
data and other pupil-level data (respectively); 3Information Governance – the processing of data in line with required standards.
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measurable benefit to the public that NPD are not required to
consider.
Navigating the numerous data request applications and re-
quired documentation was a challenge for all three studies as
it requires more than copying the information from one appli-
cation into another. NHSD plans to update their requirements
for those studies funded by National Institute for Health Re-
search (NIHR), for example where a clear patient benefit is
a requirement for funding, and thus has already been adjudi-
cated. This will allow some applications to progress quicker
but is not a solution for studies that are funded by other or-
ganisations.
The key mitigation activities during the data application
process are: 1) for researchers to understand any process
changes by monitoring data provider(s) website(s), signing up
to receive email notifications/newsletters, and attending re-
lated webinars; 2) for data providers to manage information
about their processes and to communicate any changes to re-
searchers; 3) for data providers to assign a single case officer
to enable consistent communication and project knowledge;
4) for researchers to allow the time and resources for the data
application process; and 5) for researchers and data providers
to share knowledge of the different application forms to assist
others in understanding what data providers are looking for
in the application thereby reducing the number of re-drafts
required prior to consideration by panel.
2. Project timelines
The unpredictability of how long it takes for an application
to move through the data providers’ process is affected by the
above challenges and is in itself a challenge for the project. De-
lays in applying for and accessing routinely-collected data from
multiple data providers poses a significant risk to project deliv-
ery. There is also a wider risk that public funding is wasted on
project extensions due to delays in data request applications.
This risk may deter funders from supporting projects that rely
heavily on data from external providers.
For BB:2-6, we included a feasibility stage within the
project where we requested example data from data providers
prior to the final extraction. This enabled the team to assess
data quality and prepare cleaning and analysis scripts. How-
ever, in the context of this paper, it particularly informed the
research team about their subsequent data applications (for
example, wording and documentation) to enable a faster time-
frame than previously experienced. Staff resource reflected the
anticipated workload, with reduced resource assigned during
periods of low activity and increased once data were available.
We communicated with both the study funder and the inde-
pendent study steering committee throughout this feasibility
phase, to discuss the impact of application delays on study
deliverability. Assessing the feasibility of accessing data from
multiple data providers meant we could provide reassurance to
the funders.
The LUCI study benefitted from the lessons learnt from
BB:2-6, updated the wording of the participant material, cre-
ated a participant facing website and included further detail in
the data application request on processing, benefits and out-
put. Other actions such as updating the University required
data protection notification to the Information Commissioners
Office (ICO) and ensuring review of the IG Toolkit were also
in place prior to this application.
Mitigation for data application timelines include research
teams drafting the applications, discussing with the data
providers, and talking to other teams of researchers who have
experience working with the data provider. More generally, as-
sessing feasibility is an important element to consider and com-
municate. There is, for example, a NPD user group. Sharing
of applications would also benefit other researchers; although
project details will be different, the underlying principles will
be the same. This would show the language used in the ap-
plications which would help other researchers understand how
to describe the research in sufficient detail but at a level of
understanding required by a review panel.
3. Dependencies and considerations related to
consent
The key issues identified here related to fair processing and
the amount of detail provided to participants. Fair processing
refers to the requirement, as per UK Data Protection legisla-
tion, to be transparent about how the data collected will be
used, stored and shared (25).
The data used for research are changing and so is the
public’s relationship to privacy (31). It is important to ensure
participants, whose personal data we are processing for linkage
purposes, are adequately informed about how their data will
be used for research. There are a number of models of con-
sent for health information (31) all of which fit under different
legal bases for the transfer personal information used for data
linkage (e.g. explicit consent, s251 support). Ensuring data
providers agree with the wording of participant information
sheets and consent form under their “fair processing” checks
was a challenge for all the projects.
In the example of BB:0-2, NHSD did not initially accept
the wording around the linkage element included in the par-
ticipant information sheet and consent forms used for study
recruitment. NHSD recommended modifications to the study
consent, and that all the BB:0-2 participants be re-consented
using the modified wording. Re-consenting would likely in-
troduce non-response that would impair the validity of the
sample, and in particular lead to the loss of some of the most
vulnerable participants. Recruiting to the study was a consid-
erably challenging task, as was maintaining adequate follow-
up at the required assessment time points; these were, indeed,
key rationales for obtaining routinely-collected data for the
study. Whilst we agree that meaningfully informing partic-
ipants about research access to their records is valid, there
is a challenge in providing sufficient information to potential
participants about data linkage when also presenting other re-
quired information (e.g. potentially submitting to an intensive
two-year intervention). Following an appeal, the application
was approved. The data provider maintained their preference
for alternate wording but recognised the potential damage to
the study re-consenting could cause.
NHSD will soon be introducing a nine-point check which
the panel will use to assess fair processing notices (e.g. is the
information published, is it clear and truthful, what data will
be collected?). This will enable trials which hold data from ap-
plications made before new requirements came in place, such
as BB:0-2, to continue to hold data, providing these nine con-
siderations are adequately addressed.
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Box 1 Lessons learned from addressing NHS Digital requirements (BB:2-6 study)
Demonstrating benefit to health and social care
• Referencing relevant government policies and priorities to evidence the importance of the research
• Describing how results will be disseminated to reach policy, practice and academic stakeholders to enable a benefit to
health and social care.
Clarity of planned data flow
• Highlighting critical transitions and other elements in data flows, for example, where data move from identifiable to
de-identified, who has access to the data, where data are held as individual level or aggregate,
Clarity about personnel involved in data processing
• Providing essential description of staff (and organisations) who access the data, and for what purpose (i.e. data loading,
data cleaning, data analysis)
Assuring compliance with Data Protection legislation
• For example, amending organisational notification to ICO for Universities processing the data to explicitly state data
processing for health/healthcare data and analysis/research (previously only top-level Research had been selected in
notification).
• Update to Ethics and CAG approvals so that participant facing material explicitly stated the data providers, data
requested, who will access the data and why.
Confirmation about funding source
• Letter from funder to confirm details not explicit in the confirmation of funding letter for example that ONS data will
be required for the project and study start/end dates.
Assuring Information Governance
• Ensuring all stages of the data flow pathway are supported by appropriate evidence (for example, submission from SAIL
to demonstrate their IG compliance; letter from Director of Research and Innovation Services, Cardiff University, to
confirm contracted requirements placed upon SAIL, Swansea University are in place)
• Ensuring IG Toolkit (now DSP) is maintained as up-to-date and that self-assessment has been reviewed.
Clarity about legal basis
• Highlighting how contracts held with NPD demonstrate legal basis to link to NPD data.
• Providing supplementary letter from CAG to confirm details not already explicit in confirmation letter.
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This challenge was addressed in the BB:2-6 and LUCI study
by having a participant-facing study website. This was the
main information mechanism for those who wished to opt-out
but can also be used as a means of communication for long-
term engagement of the cohorts and for updates on agreed
changes to the processing of participant data.
During the development of study materials for all three
studies the wording was reviewed by a lay group to ensure
the information was communicated in a way that the public
would understand. Ensuring a balance between providing par-
ticipants with information that is sufficiently understandable
but also comprehensive is a significant challenge. This may be
particularly the case where routine data are used as this may
be a relatively unfamiliar concept for members of the public.
Ensuring all data providers are happy with wording also posed
a challenge for BB:2-6. An agreed set of wording followed
multiple reviews by the lay group, ethics panel, confidentiality
advisory group (CAG), NHSD and NPD.
Mitigation strategies for issues related consent include flex-
ibility of research teams in responding to questions during the
application stage and updating documentation where required
(including amendments to Ethics and CAG). Use of lay in-
put can enable a strong justification for retaining the compre-
hendible participant-facing material and should continue to be
the basis for content in participant facing materials. It is in-
cumbent upon researchers to test the adequacy of draft partic-
ipant materials to establish comprehension using approaches
such as cognitive interviewing. Using other modes of com-
munication (e.g. website) is also a good way to manage and
required changes required later down the line and enhance
longer term engagement.
4. Information Governance / Security
The key issue related to this theme is the challenge both to
reach the required standard, and to provide the evidence of
this. Information Governance (IG) can be defined as the pro-
cess/es in place and controls that cover data collection, se-
curity of physical and electronic storage, use, data sharing,
archiving, and ultimately destruction of data (32). IG is of up-
most importance to all involved i.e. public, participants, data
providers and research team. Evidencing IG becomes more
complex when it involves data from multiple data providers
(32) with multiple ways to show good practice, and multiple
requirements placed on the data user.
NHSD require evidence primarily via the Data Security and
Protection (DSP) Toolkit (previously called the IG Toolkit), an
online system allowing a self-assessment against Department
of Health standards to ensure processing of NHS patient data
complies with UK legal frameworks (for example, Data Pro-
tection, common law duty of confidentiality (33), the Freedom
of Information Act 2000 etc.)(34). NPD requires completion
of a security questionnaire covering technical system details,
physical security, data handling, and staff awareness. It does
not recognise the DSP Toolkit, instead leaning more toward
an organisation being ISO-27001 compliant (35). Some data
providers such as the SAIL Databank do not allow data to be
held outside of a specified secure environment. Security / IG
evidence is not needed to access data from SAIL because SAIL
holds the data and sets standards for all data users, such as
protocols for remote data access. This set-up is useful in reas-
suring other data providers about data storage and access, but
there are some drawbacks to this e.g. accessibility (printing
and sharing of results in real time) and reliance on an external
server to maintain disk space
While all of a similar merit to ensure data security, the
different approaches pose a challenge to applicants requesting
data. The resource implications are also an area for consid-
eration. Completing and maintaining an DSP Toolkit regis-
tration is costly, especially when it is not recognised across
all data providers, and ISO accreditation would be even more
so. Interestingly, providing evidence that projects fall under
a Clinical Trials Unit (CTU), are UK Clinical Research Col-
laboration (UKCRC) registered and all staff are GCP (Good
Clinical Practice) trained, does not contribute to consideration
of an application, and in some cases cause confusion when ev-
idencing assurances around the processing of data.
Mitigation for information governance and security in-
cludes: 1) consideration of an organisation to be ISO 27001
certified or at least aligned has the benefit of a recognised
IG standard; 2) appropriately resource time to implement the
DSP Toolkit; and 3) ensure stakeholders in the broader organ-
isation (e.g. outside of the applying department) are involved
in planning / consultation. The use of data safe havens does
mitigate some of the challenges, however the researchers will
then need to choose between working with a limited subset of
data in their own environment or potentially with richer data
in restrictive settings that can hinder their productivity (21).
5. Contractual
Compliance of data access user agreements and retention of a
licence to hold data over a number of years present challenges
to university-level governance.
All data providers will issue a contract between them-
selves and the individual, project team and/or organisation
the project team work within. The challenge with working
with multiple data providers is the difference between the re-
quirements placed on the organisation and the project team
by these data providers. This includes IG but also covers data
sharing, destruction, publication and retention.
Requirements for notification of publication, acknowledge-
ment of data providers and inclusion of specific references in
those publications differ across data providers, as do data re-
tention periods and policies around cell suppression for small
numbers (Table 2). Although many of these requirements are
of similar nature, navigating these and ensuring all are adhered
to does introduce a challenge to the project and indeed a risk,
as these are contractual requirements.
For university research projects, there is a requirement to
archive data for audit purposes. For example, Cardiff Uni-
versity requires research data to be archived for a minimum
of 15 years. This puts a requirement on the research team
and/or organisation to maintain active agreements with every
data provider over 15 years to ensure archiving policies are up-
held and that different data provider periods of retention are
honoured (see Table 2). For some Data Providers a cost is
incurred following each renewal of the contract (required to
retain data) and this cost model has changed over the years.
Renewal costs will not have been included in the study budget
for projects conceived prior to these updated cost models, and
research staff will change over 15 years. These issues are be-
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ing discussed with NHSD for BB:0-2, with plans to pilot the
extension of the data sharing agreement for archived data. Un-
der a Data Archive Agreement, all NHSD data will be locked,
restricting any further access (for example for the purposes of
analyses or data checking). However, the agreement would
cover a longer period and would be at an overall reduced cost
compared to a data sharing agreement. If access to the data
is required at any point, then an application to NHSD to allow
processing (beyond archiving) will be required.
Ensuring compliance across data providers and document-
ing and evidencing these requirements was a challenge for all
three studies. We have employed a member of staff who is
responsible for ensuring policies and procedures in the depart-
ment have consideration for these contractual requirements
and that relevant studies document required evidence. In
particular, documents such as the protocol, data manage-
ment plan, statistical analysis plan and publication policy con-
tain particular sections to address these requirements. These
were developed in discussion with other universities and data
providers. An additional mitigating strategy is to seek input
from data providers to ensure studies are appropriately costed
to enable long-term retention of data.
Discussion
Summary of the challenges
The challenges presented in this paper cover five themes.
Changes to application processes and governance over time
are inevitable and understandable. As law and public attitudes
change, the availability of data and how researchers interact
with them will need to adapt (32). There are calls for propor-
tionate and principled governance (32) however this is likely to
be data provider specific, ultimately resulting in differing prin-
ciples for each data provider, as already experienced. Main-
taining communication between applicants and data providers
is key to mitigating delays where possible. The impact of de-
lays on receiving data not only risks project delivery but also
the development of staff. The rush to analyse and quality
check data in the remaining funded time can limit the extent
to which new staff can be trained in the use of these datasets,
as well as limiting time to conduct exploratory data analyses
to inform new projects and methods – a concern highlighted
by others previously (7). Ensuring participants are informed
about the study method and design in an understandable way
is an important challenge. This is especially so when data
linkage represents a small part of a larger complex RCT for
which a participant will be providing consent.
At the Administrative Data Research Network (ADRN)
conference in 2017 Julia Lane discussed the challenge of in-
formation being comprehensive (i.e. describes all necessary
details for an individual to be fully informed about the data
linkage process and privacy controls) and at the same time
comprehendible (i.e. described at a level that a lay public
member will read, understand and be able to use to make a
decision). The conclusion was that it cannot be both (36)
which reflects the challenges described here. Nevertheless, a
greater exploration about what the public already understand
and place importance upon in relation to routine data may
aid researchers when making decisions about how to inform
potential participants.
There remains more work to be done to enable researchers’
access to data for appropriate research projects. The UK gov-
ernment published their review of data security, consent and
opt-outs and highlighted the need to strike the right balance
between privacy, confidentiality and data sharing (11); while
privacy is very important, so too is data sharing (37). Cur-
rently, the re-use of such data for research requires a set of
complex approvals from multiple governing entities which are
often opaque, difficult to navigate and obtain, and so pose
risks to population based research (9).
Strengths and Limitations
These three case studies represent the experience of three
study teams within the same research centre. Although these
experiences may not be reflective of all research studies access-
ing routinely collected data, they do offer learnings that will
be applicable across trials and observational studies intending
to access individual level routinely-collected data. Further-
more, two authors worked across all three studies providing a
consistency in reviewing the challenges experienced. Neverthe-
less, this paper only focuses on the data providers applicable
to these three studies. These are major providers of routine
health and educational (including social care) data in the UK
and will have relevance to a large number of researchers and
studies. However, there may be other challenges and opportu-
nities to learn from the experience of working with other data
providers and so our own conclusions may be incomplete.
We did not specifically consider the challenges of analysing
and interpreting routinely-collected data. These are impor-
tant and valid concerns, which require on-going scrutiny but
this paper focuses on the organisational and logistic aspects
of multiple-provider working. Finally, we recognise that our
reflections place greater emphasis on the perspective of the
researcher rather than other agents, in particular the data
providers. To address this, we shared our draft manuscript
with a key contact within one of the provider organisations.
We also worked closely with the providers in managing the
process of applying for data, sometimes in the context of sig-
nificant organisational change. Nevertheless, we accept that
other issues may also be relevant which are not yet identified
in our own report. This seems inevitable given the wide range
of data users supplied by each provider and which may addi-
tionally underline the size of the task they too face in ensuring
high standards of data governance.
Recommendations
When the Partridge review was published, approximately 30%
of applications submitted to NHSD were applications from
universities (27,28). Some of the challenges presented here
may partially reflect that data users have very different in-
terests and intended uses for the data and understanding the
constraints researchers work within will be a useful message
for data providers. Our key recommendations therefore relate
to optimising communication at three different intersections
within the research / data application context.
First, the research community and data providers need to
continue their recent dialogue about data applications. The
research community is not the primary user of routine health
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Table 3: Challenges faced by the research team and proposed resolutions
Theme Challenge Resolution/Addressed how Risk1
1. Data application
process
Adapting to changes
over time
Be aware of any changes by signing up to newsletters,
email distribution lists.
Project
Length of applica-
tion process
Start discussions with data providers early on, factor in
timelines at the funding application stage.
Project
Different application
requirements for dif-
ference centres
Resource this period of time appropriately and learn
from other researchers.
Project
2. Project timelines Unpredictability Start discussions with data providers early on to be
aware of additional delays.
Project
3. Dependencies
and considerations
related to consent
Ensuring Fair pro-
cessing over long
term
Consider using other methods of communication such
as websites and seek data provider input early on to
discuss acceptable options.
Project
Comprehendible vs.
comprehensive
Ensure documentation receives review from a lay rep-
resentative and seek data provider input early on. Em-
phasis should be on it being understood. Formally test
adequacy where possible.
Project
4. Information Gov-
ernance
Differences across
providers
ISO 27001 certification; Consider use of data safe
havens to securely hold the data for the project. Appro-
priately resource time to implement the DSP Toolkit.
Ensure stakeholders in the broader organisation (e.g.
outside of the applying department) are involved in
planning / consultation.
Project & Organisation
5. Contractual Compliance with
numerous Data
Providers’ contrac-
tual requirements
Development of standard operating procedures intrinsic
to the department to address requirement.
Project & Organisation
Long-term data re-
tention
Appropriately cost studies to enable long-term reten-
tion. Seek input from data providers.
Project & Organisation
Oversight of all re-
quirements from all
providers
Employ/fund a member of staff to take responsibility
for ensuring policies and procedures in the department
have consideration for all contractual requirements.
Organisation
1 This refers to the level at which risk is implicated. Some challenges risk project delivery whereas others risk organisational
compliance and reputation.
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data but represent an important opportunity to add value to
existing data to promote public benefit. Recent initiatives such
as the UKCRC Registered Clinical Trials Unit workshop meet-
ing with NHS Digital will help data providers better understand
how data may be used and researchers better understand the
constraints on data provision that may apply to their own re-
quests.
Second, researchers using routine data need to share con-
structively their own experience of the data application pro-
cess. User groups exist already (for example, for NPD data)
although their focus may be more on analysis of the supplied
data. This paper represents one example of helping others
learning from our experiences and we hope others will be keen
to do similar.
Third, funders and data providers themselves would bene-
fit from greater dialogue. UK national funders such as NIHR
may currently support a number of studies which are access-
ing routine data and will already have had fed back to them
researchers’ experience of the application process. As men-
tioned above, different regulatory requirements may apply to
data providers such as NHSD and NPD, but some attempts
to link data across NHS and Education show the interest in
government departments in gaining research insights and value
for money by sharing data. While harmonisation across data
providers seems unfeasible, investing in attempts to identify
and enhance commonalities of approach would likely pay im-
portant dividends for the UK.
Future directions / Areas of improvement
We highlighted some challenges that fall outside of the re-
search team to mitigate. We therefore recommend that data
providers provide and maintain communication around the ap-
plication process and timelines especially when changes or de-
lays occur. Our next recommendation relates to the challenge
of archiving data and renewal of contracts, which is a risk for
organisations. Data providers need to understand the wider
research environment that researchers work within to under-
stand how their contractual requirements conflict or agree with
Good Clinical Practice (GCP) and Medicines and Healthcare
products Regulatory Agency (MHRA) guidelines. Thirdly, we
recommend that principles for data governance should be com-
mon across providers and greater movement should be made
towards a single or exchangeable system. For example, if an
organisation meets governance standards as determined by one
data provider, this should provide a high level of reassurance
across providers for working with routinely-collected data. The
growing initiative for open and accessible data to be made
available post publication is another challenge on the horizon
for studies using routinely-collected data (38). We recommend
data providers consider options to facilitate this.
A key unresolved issue from working with multiple data
providers is how best to mediate conflicting requirements. To
illustrate this, we used the example of participant information
sheets and consent forms, which provide the basis for legal
processing. Drafted participant materials may reflect the per-
spectives of researchers and guidance from lay representatives.
However, they still may conflict with either ethics committees
or requirements of data providers. In our experience funders
and ethics committees place value upon materials that have
meaningful lay input in their drafting and review. There are
established methods to determine the quality of information
provided to study participants and to improve their comprehen-
sibility. We recommend that researchers should make greater
use of these methods in preparing their study information.
Data providers may have differing requirements for such infor-
mation but these may not adequately account for the variation
in experience, understanding and literacy that may be found
in many study populations. Where study participants may be
largely drawn from harder to reach populations this is espe-
cially important. We think that ultimately the public should be
pivotal in establishing what information is provided and how.
The researcher should facilitate this and provide evidence that
such information meets standards for relevant comprehension.
Conclusions
Whilst some challenges eased in the years that these three
studies were conducted, there remain a number of important
areas for improvement. It is the responsibility of the research
community to continue to identify these areas, within and out-
side of our control, to discuss and share experiences and so-
lutions with other researchers with an objective of further im-
provement in processes for access to routinely-collected data.
The recommendations made in this paper will help researchers
better prepare for applications to multiple data providers and
highlight potential modifications for data providers as well.
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